Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

NCT02177500 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan + hydrochlorothiazide
DRUG: Telmisartan
DRUG: Placebo

Sponsor

Boehringer Ingelheim